Collplant Biotechnologies Ltd ADR (CLGN)

$0.59 -0.01 (-1.18%)
Market Cap 7.49M
Revenue (ttm) 520,000.00
Net Income (ttm) -16.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,194.23%
Debt to Equity Ratio 0.00
Volume 38,500
Avg Vol 87,910
Day's Range N/A - N/A
Shares Out 12.80M
Stochastic %K 36%
Beta 3.02
Analysts Sell
Price Target $11.00

Company Profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matri...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 73 232 5600
Fax: 972 73 232 5602
Address:
Weizmann Science Park, 4 Oppenheimer P.O. Box 4132, Rehovot, Israel
TheTradeXchange
TheTradeXchange Mar. 11 at 12:03 PM
$CLGN CLGN - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
0 · Reply
dln101
dln101 Mar. 10 at 3:04 PM
$CLGN or $GLMD close the gap first like $LGVN 🤔💪📈
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 27 at 5:44 PM
$CLGN RSI: 25.96, MACD: -0.2539 Vol: 0.46, MA20: 0.87, MA50: 1.28 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
dln101
dln101 Feb. 26 at 8:50 PM
$CLGN only $ALBT type news gets this going 🤔 similar setup 💪📈
0 · Reply
focafoca99
focafoca99 Feb. 26 at 2:43 PM
$CLGN has secured a Korean patent, but the stock isn’t reacting.
0 · Reply
dln101
dln101 Feb. 24 at 7:13 PM
$CLGN $GLMD similar setup to $EDSA before the spike with big gaps to fill.. which one goes first 🤔💪📈
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 20 at 6:42 PM
$CLGN Current Stock Price: $0.59 Contracts to trade: $5.0 CLGN Feb 20 2026 Call Entry: $0.05 Exit: $0.09 ROI: 89% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
dln101
dln101 Feb. 17 at 6:53 PM
$CLGN thought this would be running like $BDRX today after the news 🤔 https://www.tipranks.com/news/company-announcements/collplant-moves-to-capture-glp-1-driven-aesthetic-market-with-photocurable-rhcollagen-filler?utm_source=webullapp.com&utm_medium=referral
0 · Reply
panicmatt
panicmatt Feb. 17 at 8:32 AM
$CLGN Pre-revenue biotech; early-stage
0 · Reply
William_55555
William_55555 Feb. 12 at 11:58 PM
$CLGN this company is beyond a joke....
0 · Reply
Latest News on CLGN
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS

Mar 11, 2026, 8:00 AM EDT - 4 days ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS

CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler

Feb 26, 2026, 8:00 AM EST - 17 days ago

CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler

CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex

Feb 23, 2026, 7:00 AM EST - 20 days ago

CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex

CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments

Feb 17, 2026, 7:00 AM EST - 26 days ago

CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING

Feb 5, 2026, 8:00 AM EST - 5 weeks ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Nov 26, 2025, 7:30 AM EST - 3 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

Nov 18, 2025, 7:00 AM EST - 4 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

Oct 27, 2025, 7:01 AM EDT - 4 months ago

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

Oct 20, 2025, 7:00 AM EDT - 5 months ago

CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

Oct 16, 2025, 7:00 AM EDT - 5 months ago

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

Sep 30, 2025, 7:00 AM EDT - 5 months ago

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

CollPlant Expands the Distribution of its VergenixSTR Product in Europe

Sep 15, 2025, 7:00 AM EDT - 6 months ago

CollPlant Expands the Distribution of its VergenixSTR Product in Europe

CollPlant to Present at the 2025 International Conference on Biofabrication

Sep 2, 2025, 7:00 AM EDT - 6 months ago

CollPlant to Present at the 2025 International Conference on Biofabrication

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

Aug 25, 2025, 7:00 AM EDT - 7 months ago

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Aug 20, 2025, 7:00 AM EDT - 7 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

Aug 5, 2025, 7:00 AM EDT - 7 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

Jul 14, 2025, 7:00 AM EDT - 8 months ago

CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

Jun 9, 2025, 7:00 AM EDT - 9 months ago

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

Jun 4, 2025, 7:00 AM EDT - 10 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

May 30, 2025, 7:00 AM EDT - 10 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

May 28, 2025, 7:00 AM EDT - 10 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

May 14, 2025, 7:00 AM EDT - 10 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies

Apr 15, 2025, 8:00 AM EDT - 11 months ago

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies

CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 7:58 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

Mar 26, 2025, 8:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

SSYS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Mar 19, 2025, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

Feb 24, 2025, 7:00 AM EST - 1 year ago

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

CollPlant Biotechnologies Provides a Corporate Update

Feb 12, 2025, 6:00 AM EST - 1 year ago

CollPlant Biotechnologies Provides a Corporate Update

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

Nov 27, 2024, 11:36 AM EST - 1 year ago

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Nov 27, 2024, 7:00 AM EST - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Nov 12, 2024, 7:00 AM EST - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

Aug 20, 2024, 6:59 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Aug 20, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

Aug 19, 2024, 8:30 AM EDT - 1 year ago

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

SSYS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION

Aug 6, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report

Jul 29, 2024, 7:00 AM EDT - 1 year ago

CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report

CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data

Jun 6, 2024, 7:00 AM EDT - 1 year ago

CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data

CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript

May 29, 2024, 12:02 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript

CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update

May 29, 2024, 7:00 AM EDT - 1 year ago

CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

May 16, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript

Apr 4, 2024, 1:15 PM EDT - 2 years ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Apr 4, 2024, 7:17 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Mar 26, 2024, 8:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Issues Letter to Shareholders

Feb 15, 2024, 8:00 AM EST - 2 years ago

CollPlant Issues Letter to Shareholders

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

Jan 8, 2024, 7:18 AM EST - 2 years ago

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

Jan 2, 2024, 7:00 AM EST - 2 years ago

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

CollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call Transcript

Nov 29, 2023, 2:21 PM EST - 2 years ago

CollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call Transcript

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

Nov 29, 2023, 7:00 AM EST - 2 years ago

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Nov 9, 2023, 8:00 AM EST - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

Nov 1, 2023, 7:05 AM EDT - 2 years ago

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

TheTradeXchange
TheTradeXchange Mar. 11 at 12:03 PM
$CLGN CLGN - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
0 · Reply
dln101
dln101 Mar. 10 at 3:04 PM
$CLGN or $GLMD close the gap first like $LGVN 🤔💪📈
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 27 at 5:44 PM
$CLGN RSI: 25.96, MACD: -0.2539 Vol: 0.46, MA20: 0.87, MA50: 1.28 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
dln101
dln101 Feb. 26 at 8:50 PM
$CLGN only $ALBT type news gets this going 🤔 similar setup 💪📈
0 · Reply
focafoca99
focafoca99 Feb. 26 at 2:43 PM
$CLGN has secured a Korean patent, but the stock isn’t reacting.
0 · Reply
dln101
dln101 Feb. 24 at 7:13 PM
$CLGN $GLMD similar setup to $EDSA before the spike with big gaps to fill.. which one goes first 🤔💪📈
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 20 at 6:42 PM
$CLGN Current Stock Price: $0.59 Contracts to trade: $5.0 CLGN Feb 20 2026 Call Entry: $0.05 Exit: $0.09 ROI: 89% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
dln101
dln101 Feb. 17 at 6:53 PM
$CLGN thought this would be running like $BDRX today after the news 🤔 https://www.tipranks.com/news/company-announcements/collplant-moves-to-capture-glp-1-driven-aesthetic-market-with-photocurable-rhcollagen-filler?utm_source=webullapp.com&utm_medium=referral
0 · Reply
panicmatt
panicmatt Feb. 17 at 8:32 AM
$CLGN Pre-revenue biotech; early-stage
0 · Reply
William_55555
William_55555 Feb. 12 at 11:58 PM
$CLGN this company is beyond a joke....
0 · Reply
Billionairetime
Billionairetime Feb. 10 at 3:13 PM
$CLGN 💥
0 · Reply
Billionairetime
Billionairetime Feb. 10 at 3:06 PM
$CLGN
0 · Reply
Billionairetime
Billionairetime Feb. 10 at 3:00 PM
$CLGN $ENTX $XRX $KXIN $DHX going
0 · Reply
Billionairetime
Billionairetime Feb. 10 at 2:59 PM
$CLGN
0 · Reply
Billionairetime
Billionairetime Feb. 10 at 2:54 PM
$CLGN
0 · Reply
JeanBets
JeanBets Feb. 10 at 2:43 PM
$CLGN 🦍⭐️💰
0 · Reply
jamestocklover
jamestocklover Feb. 10 at 12:22 AM
$ENSC ADDED MORE. OVERSOLD ZONE. 52- WEEK LOWEST LEVELS. JUST 3M FLOAT. PURE ACCUMULATION FOR $1+💥🚀💯 $ABP 🔥 $QNCX 🔥 $CLGN 👀 $CCHH 👍
0 · Reply
RoadToAHouse
RoadToAHouse Feb. 9 at 11:27 PM
$CLGN theres that volume we needed! keep buying!
0 · Reply
JeanBets
JeanBets Feb. 9 at 11:24 PM
$CLGN 🦍⭐️💰
0 · Reply
RoadToAHouse
RoadToAHouse Feb. 9 at 11:24 PM
$CLGN look at that bounce baby
0 · Reply
RoadToAHouse
RoadToAHouse Feb. 9 at 11:23 PM
$CLGN SQUEEZE INCOMING!!!
0 · Reply